<?xml version="1.0" encoding="UTF-8"?>
<p id="p0055">Prior to the initiation of the study, serum HS and DS levels were near normal in all patients because they were receiving idursulfase, which reduces GAG accumulation in the peripheral tissues.
 <xref rid="bib21" ref-type="bibr">
  <sup>21</sup>
 </xref> Their HS and DS levels remained substantially unchanged throughout the study period (i.e., after JR-141 administration; 
 <xref rid="fig3" ref-type="fig">Figure 3</xref>A). Urinary HS and DS levels were also in the normal or near-normal range before and during the study period (
 <xref rid="fig3" ref-type="fig">Figure 3</xref>B). Although a treatment period of 4 weeks is too short to render these results conclusive, they nonetheless may suggest potential non-inferiority of JR-141 to idursulfase in reducing GAG accumulation in the peripheral tissues.
</p>
